These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 1720845)
21. Tedisamil inactivates transient outward K+ current in rat ventricular myocytes. Dukes ID; Morad M Am J Physiol; 1989 Nov; 257(5 Pt 2):H1746-9. PubMed ID: 2556052 [TBL] [Abstract][Full Text] [Related]
22. Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. Curtis MJ; Hearse DJ J Mol Cell Cardiol; 1989 Jan; 21(1):21-40. PubMed ID: 2716065 [TBL] [Abstract][Full Text] [Related]
23. Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation. Friedrichs GS; Abreu JN; Driscoll EM; Borlak J; Lucchesi BR J Cardiovasc Pharmacol; 1998 Jan; 31(1):56-66. PubMed ID: 9456278 [TBL] [Abstract][Full Text] [Related]
24. Anion manipulation: a new antiarrhythmic approach. Action of substitution of chloride with nitrate on ischemia- and reperfusion-induced ventricular fibrillation and contractile function. Ridley PD; Curtis MJ Circ Res; 1992 Apr; 70(4):617-32. PubMed ID: 1551189 [TBL] [Abstract][Full Text] [Related]
25. Delay of occurrence of reperfusion-induced ventricular fibrillation in the isolated rat heart with superoxide dismutase. Koerner JE; Dage RC J Cardiovasc Pharmacol; 1990 Sep; 16(3):461-7. PubMed ID: 1700219 [TBL] [Abstract][Full Text] [Related]
26. Effects of tedisamil on cardiovascular tissues isolated from normo- and hypertensive rats. Doggrell SA; Nand V J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):261-72. PubMed ID: 11584333 [TBL] [Abstract][Full Text] [Related]
27. Hemodynamic, antiischemic, and neurohumoral effects of tedisamil and atenolol in patients with coronary artery disease. Mitrovic V; Miskovic A; Strau M; Thormann J; Pitschner H; Hamm C Cardiovasc Drugs Ther; 2000 Oct; 14(5):511-21. PubMed ID: 11101199 [TBL] [Abstract][Full Text] [Related]
28. Mechanism of procainamide-induced prevention of spontaneous wave break during ventricular fibrillation. Insight into the maintenance of fibrillation wave fronts. Kim YH; Yashima M; Wu TJ; Doshi R; Chen PS; Karagueuzian HS Circulation; 1999 Aug; 100(6):666-74. PubMed ID: 10441106 [TBL] [Abstract][Full Text] [Related]
30. Protection by ITF 1300, a heparin ion-pair complex, against arrhythmias induced by regional ischemia and reperfusion in the isolated rat heart: possible mechanism of action. Curtis MJ; Barsby RW; Forster R J Cardiovasc Pharmacol; 1995 Apr; 25(4):643-51. PubMed ID: 7596134 [TBL] [Abstract][Full Text] [Related]
31. KC8851, a tedisamil analogue with mixed channel blockade, exhibits antiarrhythmic properties against ischemia- and electrically-induced arrhythmias. Xu R; Abraham S; McLarnon JG; Walker MJ Life Sci; 1997; 61(3):237-48. PubMed ID: 9217283 [TBL] [Abstract][Full Text] [Related]
32. Tacrine inhibits ventricular fibrillation induced by ischaemia and reperfusion and widens QT interval in rat. Rees SA; Curtis MJ Cardiovasc Res; 1993 Mar; 27(3):453-8. PubMed ID: 8490946 [TBL] [Abstract][Full Text] [Related]
33. Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmias and cardiac membrane currents. Takahara A; Uneyama H; Sasaki N; Ueda H; Dohmoto H; Shoji M; Hara Y; Nakaya H; Yoshimoto R J Cardiovasc Pharmacol; 1999 Apr; 33(4):625-32. PubMed ID: 10218734 [TBL] [Abstract][Full Text] [Related]